Skip to main content

Table 1 The association between antihistamines and LEDD

From: Integration of National Health Insurance claims data and animal models reveals fexofenadine as a promising repurposed drug for Parkinson’s disease

Antihistamine

Exposed case

Antihistamine-unexposed group

Antihistamine-exposed group

 
  

LEDD

LEDD

Difference

Ratio

LEDD

LEDD

Difference

Ratio

p-value

  

Before index

After index

  

Before index

After index

   

Overall

24,150

258.143

263.982

5.839

5.607

263.127

267.32

4.193

6.208

0.17

1st generation

13,391

257.533

263.655

6.122

5.63

272.614

276.255

3.641

4.919

0.369

 Chlorpheniramine

4832

256.555

260.456

3.901

4.575

289.544

290.461

0.916

3.35

0.011*

 Clemastine

28

245.797

252.404

6.607

5.828

260.051

254.51

-5.54

0.833

0.378

 Dimenhydrinate

6481

256.032

263.127

7.095

6.042

251.093

257.03

5.937

6.821

0.127

 Hydroxyzine

2050

256.758

261.798

5.04

3.935

271.368

271.564

0.196

2.748

0.051

2nd generation

10,759

257.571

263.582

6.011

5.586

253.639

258.385

4.745

7.497

0.09

 Azelastine

1098

258.29

264.081

5.791

5.807

280.206

284.477

4.271

4.977

0.681

 Bepotastine

2086

256.223

263.149

6.926

6.328

252.281

256.457

4.176

5.229

0.243

 Cetirizine

1685

261.267

267.499

6.232

5.422

268.424

273.625

5.201

6.118

0.492

 Desloratadine

65

262.288

272.612

10.323

6.893

247.033

238.168

-8.865

3.057

0.341

 Ebastine

599

260.882

267.265

6.383

6.278

260.019

272.092

12.073

9.224

0.088

 Fexofenadine

1356

253.307

266.844

13.537

9.399

253.276

258.86

5.584

6.997

0.045*

 Ketotifen

147

258.036

259.198

1.163

4.706

264.295

276.573

12.279

9.575

0.162

 Levocetirizine

2384

257.333

269.701

12.373

8.309

258.232

263.3

5.068

6.35

0.046*

 Loratadine

374

266.108

273.866

-7.758

5.128

261.734

256.611

-5.124

2.15

0.087

 Olopatadine

965

259.044

268.828

9.784

8.341

209.294

235.14

25.846

27.218

 < 0.001***

  1. *p < 0.05, ***p < 0.001